In addition, inhibition or silencing of APE1 dramatically enhances cancer cell sensitivity to radiotherapy in prostate cancer20, colorectal cancer21, non-small-cell lung cancer22, pancreatic cancer23, and hepatocellular carcinoma24, suggesting an association between APE1 and radiosensitivity across different cancer types. This evidence concerns the gene APEX1 and cancer.